Skip to main content
. 2016 Sep 20;7(46):75261–75272. doi: 10.18632/oncotarget.12127

Table 1. Clinical data of the patients included in the study.

Patients' characteristics N (%)
Patients 51
 Male 38 (74.5%)
 Female 13 (25.5%)
Age (years)
 Mean ± SD 66.2 ± 13.0
 Median 68
 Minimum/Maximum 36/90
Histology
 SDC de novo 39 (76.5%)
 SDC ex pleomorphic adenoma 12 (23.5%)
Resection margins
 R0 25 (49.0%)
 R1 17 (33.3%)
 R2 1 (2.0%)
 Rx 8 (15.7%)
pT-stage
 pTx 1 (2.0%)
 pT1 12 (23.5%)
 pT2 5 (9.8%)
 pT3 16 (31.4%)
 pT4a 16 (31.4%)
 pT4b 1 (2.0%)
pN-stage
 pNx 2 (3.9%)
 pN0 10 (19.6%)
 pN1 8 (15.7%)
 pN2 30 (58.8%)
 pN3 1 (2.0%)
Extracapsular spread
 Unknown 23 (45.1%)
 Yes 15 (29.4%)
 No 13 (25.5%)
cM-stage
 cMx 12 (23.6%)
 cM0 30 (58.8%)
 cM1 9 (17.6%)
Lymphangiosis
 Unknown 15 (29.4%)
 Yes 22 (43.1%)
 No 14 (27.5%)
Hemangiosis
 Unknown 18 (35.3%)
 Yes 14 (27.5%)
 No 19 (37.3%)
Perineural invasion
 Unknown 19 (37.3%)
 Yes 22 (43.1%)
 No 10 (19.6%)
Type of parotidectomy
 Unknown 1 (2.0%)
 Lateral 4 (7.8%)
 Total 24 (47.1%)
 Radical 20 (39.2%)
 Subtotal 2 (3.9%)
Neck dissection
 Yes 49 (96.1%)
 No 2 (3.9%)